UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
Lockheed Martin
LMT
|
+$388M |
| 3 |
Baidu
BIDU
|
+$301M |
| 4 |
TAL Education Group
TAL
|
+$291M |
| 5 |
Microsoft
MSFT
|
+$278M |
Top Sells
| 1 |
Mastercard
MA
|
+$412M |
| 2 |
Adobe
ADBE
|
+$385M |
| 3 |
Veeva Systems
VEEV
|
+$332M |
| 4 |
Global Payments
GPN
|
+$331M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$298M |
Sector Composition
| 1 | Technology | 25.11% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Healthcare | 12.46% |
| 4 | Financials | 11.55% |
| 5 | Communication Services | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLRN
701
DELISTED
Acceleron Pharma Inc.
XLRN
| $30.5M | 0.01% |
238,749
+5,426
| +2% | +$694K |
|
|
ARNA
702
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $30.5M | 0.01% |
397,172
+232,837
| +142% | +$17.9M |
|
703
Zymeworks
ZYME
$1.16B
| $30.5M | 0.01% |
644,960
+3,587
| +0.6% | +$170K |
|
704
Brixmor Property Group
BRX
$8.52B
| $30M | 0.01% |
1,813,976
+231,355
| +15% | +$3.83M |
|
705
EastGroup Properties
EGP
$8.8B
| $29.9M | 0.01% |
216,434
+29,895
| +16% | +$4.13M |
|
|
EQC
706
DELISTED
Equity Commonwealth
EQC
| $29.7M | 0.01% |
1,088,771
-28,500
| -3% | -$777K |
|
707
TG Therapeutics
TGTX
$5.05B
| $29.7M | 0.01% |
570,677
-72,256
| -11% | -$3.76M |
|
708
Cousins Properties
CUZ
$4.83B
| $29.7M | 0.01% |
885,200
+113,442
| +15% | +$3.8M |
|
709
Douglas Emmett
DEI
$2.71B
| $29.5M | 0.01% |
1,009,890
+158,472
| +19% | +$4.62M |
|
710
GDS Holdings
GDS
$6.41B
| $29.4M | 0.01% |
314,279
+90,206
| +40% | +$8.45M |
|
711
XPeng
XPEV
$19.2B
| $29.4M | 0.01% |
685,741
+450,067
| +191% | +$19.3M |
|
712
Chart Industries
GTLS
$8.94B
| $29.3M | 0.01% |
248,591
-7,777
| -3% | -$916K |
|
713
Knight Transportation
KNX
$6.98B
| $29.2M | 0.01% |
698,610
+236,440
| +51% | +$9.89M |
|
714
Highwoods Properties
HIW
$3.43B
| $29.2M | 0.01% |
736,221
+73,974
| +11% | +$2.93M |
|
715
Aramark
ARMK
$10.1B
| $29.1M | 0.01% |
1,046,683
+19,948
| +2% | +$554K |
|
716
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.8B
| – | – |
0
| – | -$176M |
|
717
Axalta
AXTA
$6.82B
| $28.4M | 0.01% |
995,332
+83,087
| +9% | +$2.37M |
|
718
Chemed
CHE
$6.7B
| $28.3M | 0.01% |
53,115
+28,292
| +114% | +$15.1M |
|
719
Ironwood Pharmaceuticals
IRWD
$175M
| $27.8M | 0.01% |
2,444,263
-1,009,979
| -29% | -$11.5M |
|
720
Autohome
ATHM
$3.46B
| $27.7M | 0.01% |
277,684
-178,003
| -39% | -$17.7M |
|
721
Southern Copper
SCCO
$82.2B
| $27.5M | 0.01% |
442,908
+73,333
| +20% | +$4.55M |
|
722
Planet Fitness
PLNT
$8.64B
| $27.2M | 0.01% |
350,965
+103,952
| +42% | +$8.07M |
|
723
Erie Indemnity
ERIE
$17.4B
| $27.2M | 0.01% |
110,890
+15,731
| +17% | +$3.86M |
|
724
SL Green Realty
SLG
$4.23B
| $27.1M | 0.01% |
442,093
+44,376
| +11% | +$2.72M |
|
725
PTC Therapeutics
PTCT
$4.65B
| $27.1M | 0.01% |
444,142
+16,702
| +4% | +$1.02M |
|